How much do paid clinical trials in Grand Rapids pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Are clinical trials in Grand Rapids safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

How do I join a study in Grand Rapids, MI?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

How often do new paid studies open in Grand Rapids?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Grand Rapids.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Grand Rapids typically complete one or two studies per year.

Paid Clinical Trials Grand Rapids, MI — 455 Studies Recruiting (Jul 2026)

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Solid Tumor, Non-Small-Cell Lung Cancer Phase 1 Interventional 364 participants sought

START Midwest — Grand Rapids, Michigan (0.6 mi) · Sponsor: Astellas Pharma Inc

See eligibility & contact on ClinicalTrials.gov (NCT07094204)

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

Adult Congenital Heart Disease, Congenital Heart Disease N/A Observational 400 participants sought

Helen DeVos Children's Hospital — Grand Rapids, Michigan (0.6 mi) · Sponsor: Leiden University Medical Center

See eligibility & contact on ClinicalTrials.gov (NCT06932081)

Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

Advanced Solid Tumor, Metastatic Solid Tumor Phase 1 Interventional 220 participants sought

START Midwest — Grand Rapids, Michigan (0.6 mi) · Sponsor: Circle Pharma

See eligibility & contact on ClinicalTrials.gov (NCT06577987)

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis, Ulcerative Colitis Chronic Phase 2 Interventional 140 participants sought

Gastroenterology Associates of Western Michigan, P.L.C. — Wyoming, Michigan (4.2 mi) · Sponsor: Eli Lilly and Company

See eligibility & contact on ClinicalTrials.gov (NCT06598943)

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Multiple conditions Phase 2 Interventional 150 participants sought

Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan (0.6 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05136196)

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

Advanced Solid Tumor, Adult, ERBB2 Altered Breast Cancer Phase 1 Interventional 100 participants sought

START Midwest — Grand Rapids, Michigan (0.6 mi) · Sponsor: Cogent Biosciences, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07361562)

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

Intracerebral Hemorrhage, Stroke N/A Observational 1,018 participants sought

University of Michigan Health-West — Wyoming, Michigan (4.2 mi) · Sponsor: Zeenat Qureshi Stroke Institute

See eligibility & contact on ClinicalTrials.gov (NCT06402968)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought

Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital — Grand Rapids, Michigan (0.6 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06172296)

A Study of YL242 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor Phase 1, Phase 2 Interventional 424 participants sought

US-206 — Grand Rapids, Michigan (0.6 mi) · Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

See eligibility & contact on ClinicalTrials.gov (NCT07197827)

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Locally Advanced / Metastatic Solid Tumors Phase 1, Phase 2 Interventional 290 participants sought

Clinical Study Site — Grand Rapids, Michigan (0.6 mi) · Sponsor: Crescent Biopharma, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07335497)

Stroke Thrombectomy and Aneurysm Registry

Stroke, Thromboses, Intracranial N/A Observational 40,000 participants sought

University of Michigan Health-West — Wyoming, Michigan (4.2 mi) · Sponsor: Medical University of South Carolina

See eligibility & contact on ClinicalTrials.gov (NCT04994756)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought

Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan (0.6 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT04566328)

The CONFORM Pivotal Trial

Atrial Fibrillation, Stroke N/A Interventional 1,600 participants sought

Corewell Health — Grand Rapids, Michigan (0.6 mi) · Sponsor: Conformal Medical, Inc

See eligibility & contact on ClinicalTrials.gov (NCT05147792)

A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

Ovarian Neoplasms, Endometrial Neoplasms Phase 1 Interventional 495 participants sought

South Texas Accelerated Research Therapeutics (START) Midwest — Grand Rapids, Michigan (0.6 mi) · Sponsor: Eli Lilly and Company

See eligibility & contact on ClinicalTrials.gov (NCT06400472)

A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.

Advanced Solid Tumors Phase 1 Interventional 40 participants sought

START - Midwest — Grand Rapids, Michigan (0.6 mi) · Sponsor: FoRx Therapeutics AG

See eligibility & contact on ClinicalTrials.gov (NCT07356453)

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

Prostatic Neoplasms, Castration-Resistant Phase 1, Phase 2 Interventional 54 participants sought

BAMF Health — Grand Rapids, Michigan (0.6 mi) · Sponsor: Clarity Pharmaceuticals Ltd

See eligibility & contact on ClinicalTrials.gov (NCT04868604)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought

Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan (0.6 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06337318)

Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age

Amblyopia Phase 3 Interventional 252 participants sought

Pediatric Ophthalmology, P.C. — Grand Rapids, Michigan (0.6 mi) · Sponsor: Jaeb Center for Health Research

See eligibility & contact on ClinicalTrials.gov (NCT06524882)

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms Phase 3 Interventional 1,314 participants sought

Cancer and Hematology Centers of Western Michigan ( Site 0005) — Grand Rapids, Michigan (0.6 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT06136650)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought

Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan (0.6 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT07198074)

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohns Disease Phase 3 Interventional 425 participants sought

Gastroenterology Associates of Western Michigan, P.L.C. — Wyoming, Michigan (4.2 mi) · Sponsor: Hoffmann-La Roche

See eligibility & contact on ClinicalTrials.gov (NCT06819891)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought

Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan (0.6 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)

Radiotracer, Hypertension EARLY/Phase 1 Interventional 24 participants sought

BAMF Health, Inc. — Grand Rapids, Michigan (0.6 mi) · Sponsor: Benjamin Viglianti

See eligibility & contact on ClinicalTrials.gov (NCT04546126)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought

Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan (0.6 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT04251052)

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

Prostate Cancer Castration-resistant Prostate Cancer, Breast Cancer Phase 1, Phase 2 Interventional 150 participants sought

START, Midwest — Grand Rapids, Michigan (0.6 mi) · Sponsor: MBrace Therapeutics

See eligibility & contact on ClinicalTrials.gov (NCT07145255)

Paid Clinical Trials in Grand Rapids, MI

Studies recruiting near Grand Rapids right now

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

A Study of YL242 in Subjects With Advanced Solid Tumors

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Stroke Thrombectomy and Aneurysm Registry

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

The CONFORM Pivotal Trial

A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

Top-rated research centers in Grand Rapids

MSU Grand Rapids Research Center

Cancer Research Consortium of West Michigan

West Michigan Clinical Research Center

Imperial Clinical Research Services

Beat Childhood Cancer Research Consortium

BAMF Health

The Cancer & Hematology Centers

Corewell Health Graduate Medical Education

Vivid IV Health

Clinical trials in Grand Rapids: what's recruiting

How to enroll in a paid study in Grand Rapids

Frequently asked questions

Paid clinical trials near Grand Rapids

More of MI

New paid studies open every week